These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31689108)

  • 1. Bioisosteric Development of Multitarget Nonsteroidal Anti-Inflammatory Drug-Carbonic Anhydrases Inhibitor Hybrids for the Management of Rheumatoid Arthritis.
    Bua S; Lucarini L; Micheli L; Menicatti M; Bartolucci G; Selleri S; Di Cesare Mannelli L; Ghelardini C; Masini E; Carta F; Gratteri P; Nocentini A; Supuran CT
    J Med Chem; 2020 Mar; 63(5):2325-2342. PubMed ID: 31689108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis.
    Bua S; Di Cesare Mannelli L; Vullo D; Ghelardini C; Bartolucci G; Scozzafava A; Supuran CT; Carta F
    J Med Chem; 2017 Feb; 60(3):1159-1170. PubMed ID: 28075587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Management of Rheumatoid Arthritis.
    Akgul O; Di Cesare Mannelli L; Vullo D; Angeli A; Ghelardini C; Bartolucci G; Alfawaz Altamimi AS; Scozzafava A; Supuran CT; Carta F
    J Med Chem; 2018 Jun; 61(11):4961-4977. PubMed ID: 29746127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain Relieving Effect of-NSAIDs-CAIs Hybrid Molecules: Systemic and Intra-Articular Treatments against Rheumatoid Arthritis.
    Micheli L; Bozdag M; Akgul O; Carta F; Guccione C; Bergonzi MC; Bilia AR; Cinci L; Lucarini E; Parisio C; Supuran CT; Ghelardini C; Di Cesare Mannelli L
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003542
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and Evaluation of Carbonic Anhydrase Inhibitors with Carbon Monoxide Releasing Properties for the Management of Rheumatoid Arthritis.
    Berrino E; Milazzo L; Micheli L; Vullo D; Angeli A; Bozdag M; Nocentini A; Menicatti M; Bartolucci G; di Cesare Mannelli L; Ghelardini C; Supuran CT; Carta F
    J Med Chem; 2019 Aug; 62(15):7233-7249. PubMed ID: 31287314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of co-eluting isomers of anti-inflammatory drugs conjugated to carbonic anhydrase inhibitors from plasma in liquid chromatography by energy-resolved tandem mass spectrometry.
    Menicatti M; Pallecchi M; Bua S; Vullo D; Di Cesare Mannelli L; Ghelardini C; Carta F; Supuran CT; Bartolucci G
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):671-679. PubMed ID: 29536775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of New NSAID-CAI Hybrid Compounds in Inflammation and Lung Fibrosis.
    Lucarini L; Durante M; Sgambellone S; Lanzi C; Bigagli E; Akgul O; Masini E; Supuran CT; Carta F
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis.
    Matheson AJ; Figgitt DP
    Drugs; 2001; 61(6):833-65. PubMed ID: 11398914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Insights on CAI-CORM Hybrids: Evaluation of the CO Releasing Properties and Pain-Relieving Activity of Differently Substituted Coumarins for the Treatment of Rheumatoid Arthritis.
    Berrino E; Micheli L; Carradori S; di Cesare Mannelli L; Guglielmi P; De Luca A; Carta F; Ghelardini C; Secci D; Supuran CT
    J Med Chem; 2023 Feb; 66(3):1892-1908. PubMed ID: 36701258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharma-clinics. The drug of the month. Celecoxib (Celebrex)].
    Scheen AJ
    Rev Med Liege; 2001 Jan; 56(1):53-5. PubMed ID: 11256140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrids of carbonic anhydrase and cyclooxygenase inhibitors attenuate cardiac hypoxic inflammatory injuries.
    Zhou W; Wang C; Zhang B; Gou S
    Eur J Pharmacol; 2023 Jul; 950():175751. PubMed ID: 37116562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of selective COX-2 inhibitors.
    Capone ML; Tacconelli S; Sciulli MG; Patrignani P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anti-inflammatory activity of sulfonamides and carboxylates incorporating trimellitimides: Dual cyclooxygenase/carbonic anhydrase inhibitory actions.
    Abdel-Aziz AA; Angeli A; El-Azab AS; Hammouda MEA; El-Sherbeny MA; Supuran CT
    Bioorg Chem; 2019 Mar; 84():260-268. PubMed ID: 30508771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II.
    Knudsen JF; Carlsson U; Hammarström P; Sokol GH; Cantilena LR
    Inflammation; 2004 Oct; 28(5):285-90. PubMed ID: 16134002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rofecoxib: its efficacy in rheumatoid arthritis and acute pain].
    Morović-Vergles J
    Reumatizam; 2003; 50(2):47-8. PubMed ID: 15098376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic therapy for rheumatoid arthritis: nonsteroidal anti-inflammatory drugs.
    Daoud KF; Jackson CG; Williams HJ
    Compr Ther; 1999; 25(8-10):427-33. PubMed ID: 10520445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX 2-selective NSAIDs: biology, promises, and concerns.
    Mandell BF
    Cleve Clin J Med; 1999 May; 66(5):285-92. PubMed ID: 10330781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis. New disease-modifying and anti-inflammatory drugs.
    Infante R; Lahita RG
    Geriatrics; 2000 Mar; 55(3):30-2, 35-6, 39-40. PubMed ID: 10732003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results.
    Tindall E
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase inhibitors are antiarthritic in the rat.
    Nolan JC; Gathright CE; Radvany CH; Barrett RJ; Sancilio LF
    Pharmacol Res; 1991 Dec; 24(4):377-83. PubMed ID: 1805191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.